![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012
October 23, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Scientists Publish the Discovery of Novel Allosteric Modulators for the Key Therapeutic Targets HCV NS3 and PKM2 in Nature Journals
October 15, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces the Appointment of President Harren Jhoti, PhD to the BioIndustry Association Board of Directors
October 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Earns $5 Million for First Commercial Sale of DACOGEN(R) in the European Union
October 09, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Platinum-Resistant Recurrent Ovarian Cancer Patients
October 02, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at BIO Investor Forum
October 02, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia
September 28, 2012 06:20 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
September 21, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences
September 18, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients
September 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...